Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Baillie

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Drug Metabolism Reviews|November 21, 2014
The contributions of Sidney D. Nelson to drug metabolism researchThomas A Baillie
Expert Opinion on Drug Discovery|October 2, 2020
Approaches to mitigate the risk of serious adverse reactions in covalent drug designThomas A Baillie
Chemical Research in Toxicology|July 18, 2006
Future of toxicology-metabolic activation and drug design: challenges and opportunities in chemical toxicologyThomas A Baillie
Angewandte Chemie (International Ed. in English)|August 20, 2016
Targeted Covalent Inhibitors for Drug DesignThomas A Baillie
Chemical Research in Toxicology|February 17, 2009
Approaches to the assessment of stable and chemically reactive drug metabolites in early clinical trialsThomas A Baillie
Chemical Research in Toxicology|December 7, 2007
Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolismThomas A Baillie
Science (New York, N.Y.)|March 20, 2004
Organic chemistry in drug discoveryMalcolm MacCoss, Thomas A Baillie
Drug Metabolism and Pharmacokinetics|October 28, 2010
Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolismThomas A Baillie, Allan E Rettie
Drug Discovery Today|May 18, 2005
Bridging cheminformatic metabolite prediction and tandem mass spectrometryM Reza Anari, Thomas A Baillie
Drug Metabolism Reviews|December 6, 2006
Addressing metabolic activation as an integral component of drug designGeorge A Doss, Thomas A Baillie
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Drug Metabolism Reviews|November 21, 2014
The contributions of Sidney D. Nelson to drug metabolism researchThomas A Baillie
Expert Opinion on Drug Discovery|October 2, 2020
Approaches to mitigate the risk of serious adverse reactions in covalent drug designThomas A Baillie
Chemical Research in Toxicology|July 18, 2006
Future of toxicology-metabolic activation and drug design: challenges and opportunities in chemical toxicologyThomas A Baillie
Angewandte Chemie (International Ed. in English)|August 20, 2016
Targeted Covalent Inhibitors for Drug DesignThomas A Baillie
Chemical Research in Toxicology|February 17, 2009
Approaches to the assessment of stable and chemically reactive drug metabolites in early clinical trialsThomas A Baillie
Chemical Research in Toxicology|December 7, 2007
Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolismThomas A Baillie
Science (New York, N.Y.)|March 20, 2004
Organic chemistry in drug discoveryMalcolm MacCoss, Thomas A Baillie
Drug Metabolism and Pharmacokinetics|October 28, 2010
Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolismThomas A Baillie, Allan E Rettie
Drug Discovery Today|May 18, 2005
Bridging cheminformatic metabolite prediction and tandem mass spectrometryM Reza Anari, Thomas A Baillie
Drug Metabolism Reviews|December 6, 2006
Addressing metabolic activation as an integral component of drug designGeorge A Doss, Thomas A Baillie
Pageof 6